Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study — Stella

Recruiting

Back to Chronic Inflammatory Demyelinating Polyradiculoneuropathy trials

Trial locations(19 sites)

United States

PPD Virtual, Wilmington, North Carolina

Germany

Jüdisches Krankenhaus Berlin, Berlin

Universitätsklinikum Düsseldorf, Düsseldorf

Universitätsklinikum Frankfurt, Frankfurt

UKGM - Universitätsklinikum Gießen und Marburg GmbH, Giessen

Key details

Sponsor

argenx

Enrollment target

~200 participants

Started

August 2025

Primary completion

October 2029

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov